Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44
Margaret Yeh, Yin-Ying Wang, Ji Young Yoo, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay
Shereen Saeid Elshaer, Ahmed I. Abulsoud, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154511-154511
Closed Access | Times Cited: 55
MiRNAs as major players in brain health and disease: current knowledge and future perspectives
Sarika V. Kapplingattu, Sujata Bhattacharya, Yogita K. Adlakha
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
A Narrative Review on CD44’s Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence
Akihiro Inoue, Takanori Ohnishi, Masahiro Nishikawa, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4898-4898
Open Access | Times Cited: 17
The Role of microRNAs in Multidrug Resistance of Glioblastoma
Parvaneh Mahinfar, Behnaz Mansoori, Davoud Rostamzadeh, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3217-3217
Open Access | Times Cited: 25
Dysregulated miRNAs in Progression and Pathogenesis of Alzheimer’s Disease
Tania Arora, Vikash Prashar, Randeep Singh, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6107-6124
Closed Access | Times Cited: 25
Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers
Julian M. Rozenberg, Anton Buzdin, Tharaa Mohammad, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Scrutinizing the landscape of DNA methylation epigenetic face(s) in glioblastomas
Nadia Μ. Hamdy, Mariam M. Gabr, Sherihan G. AbdelHamid, et al.
Elsevier eBooks (2024), pp. 467-504
Closed Access | Times Cited: 4
Unlocking novel therapeutic avenues in glioblastoma: Harnessing 4-amino cyanine and miRNA synergy for next-gen treatment convergence
K Sandhanam, Tamilanban Thamaraikani, K. Manasa, et al.
Neuroscience (2024) Vol. 553, pp. 1-18
Closed Access | Times Cited: 4
Decreased PAX6 and DSG1 Protein Expression in Corneal Epithelium of Patients with Epithelial Basal Membrane Dystrophy, Salzmann Nodular Degeneration, and Pterygium
Tanja Stachon, Fabian N. Fries, Zhen Li, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1456-1456
Open Access
Systematic characterization and biological functions of non‐coding RNAs in glioblastoma
Lirui Dai, Wulong Liang, Zimin Shi, et al.
Cell Proliferation (2022) Vol. 56, Iss. 3
Open Access | Times Cited: 18
Unraveling the noncoding RNA landscape in glioblastoma: from pathogenesis to precision therapeutics
K. Sandhanam, Tamilanban Thamaraikani
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9475-9502
Closed Access | Times Cited: 3
The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer
Ф. М. Кипкеева, Tatyana Muzaffarova, А. А. Коротаева, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9324-9324
Open Access | Times Cited: 13
Non-coding RNAs enhance the apoptosis efficacy of therapeutic agents used for the treatment of glioblastoma multiform
Shokoofeh Ghaemi, Zahra Fekrirad, Nina Zamani, et al.
Journal of drug targeting (2022) Vol. 30, Iss. 6, pp. 589-602
Closed Access | Times Cited: 11
Extracellular vesicles in human milk
Regina Golan‐Gerstl, Shimon Reif
Current Opinion in Clinical Nutrition & Metabolic Care (2022) Vol. 25, Iss. 3, pp. 209-215
Closed Access | Times Cited: 11
Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power
James S. Brown
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105206-105206
Closed Access | Times Cited: 4
miR-3174 Is a New Tumor Suppressor MicroRNA That Inhibits Several Tumor-Promoting Genes in Glioblastoma
Farina Hanif, Ying Zhang, Collin Dube, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9326-9326
Open Access | Times Cited: 4
Discovery of miRNA–mRNA regulatory networks in glioblastoma reveals novel insights into tumor microenvironment remodeling
Iulia A Grigore, A. Rajagopal, Jonathan Tak-Sum Chow, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
LINC02381-ceRNA exerts its oncogenic effect through regulation of IGF1R signaling pathway in glioma
Hossein Nemati, Masoumeh Fakhre-Taha, Amir‐Reza Javanmard, et al.
Journal of Neuro-Oncology (2022) Vol. 158, Iss. 1, pp. 1-13
Closed Access | Times Cited: 6
Novel Therapeutics and drug-delivery Approaches in the Modulation of Glioblastoma Stem Cell Resistance
Shelby B. Smiley, Hamideh Zarrinmayeh, Sudip Das, et al.
Therapeutic Delivery (2022) Vol. 13, Iss. 4, pp. 249-273
Open Access | Times Cited: 6
Concise review: Cancer cell reprogramming and therapeutic implications
Xue Xiao, Hua Chen, Lili Yang, et al.
Translational Oncology (2022) Vol. 24, pp. 101503-101503
Open Access | Times Cited: 6
Antiproliferative activity of CD44 siRNA-PEI-PEG nanoparticles in glioblastoma
Parvaneh Mahinfar, Ahad Mokhtarzadeh, Behzad Baradaran, et al.
Research in Pharmaceutical Sciences (2021) Vol. 17, Iss. 1, pp. 78-85
Open Access | Times Cited: 8
Negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cells and patient prognosis after breast cancer surgery
Fang Xin Jian, Peng Xiao Bao, Wang Fu Li, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin
Ji Young Yoo, Margaret Yeh, Yin‐Ying Wang, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 780-780
Open Access | Times Cited: 7
Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221‐3p/222‐3p axis in glioblastoma
Nargis Malik, Archismita Kundu, Yakhlesh Gupta, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 12, pp. 1817-1831
Closed Access | Times Cited: 2
miR-342-3p Suppresses glioblastoma development via targeting CDK6
Jianli Yao, Yujian Dai, Zhen Yu Liu, et al.
Acta Biochimica Polonica (2022)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top